Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma

Cancer Epidemiology

Volumn 36, Issue 4, 2012, Pages 391-394

  Hauser, Stefan ^a   Wulfken, Lena M ^a   Holdenrieder, Stefan ^a   Moritz, Rudolf ^b   Ohlmann, Carsten Henning ^c   Jung, Volker ^c   Becker, Frank ^c,d   Herrmann, Edwin ^b   Walgenbach Brünagel, Gisela ^a   von Ruecker, Alexander ^a   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d Urologische Gemeinschaftspraxis und Ambulatorium Derouet/Poenicke/Becker   (Germany)

Author keywords

Biomarkers; Diagnosis; MicroRNA; MiR 378; Renal cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 191; MICRORNA 26A 2; MICRORNA 337 3P; MICRORNA 378; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MICRORNA BLOOD LEVEL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; VALIDATION PROCESS;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84863465388     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.04.001     Document Type: Article

References (15)

1. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
2. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3:e3694.
3. Mahn R., Heukamp L.C., Rogenhofer S., von Ruecker A., Muller S.C., Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011, 77:1265.
4. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
5. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010, 251:499-505.
6. Brase J.C., Johannes M., Schlomm T., Falth M., Haese A., Steuber T., et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011, 128:608-616.
7. Wulfken L.M., Moritz R., Ohlmann C., Holdenrieder S., Jung V., Becker F., et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS ONE 2011, 6:e25787.
8. Keller A., Leidinger P., Bauer A., Elsharawy A., Haas J., Backes C., et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011, 8:841-843.
9. Chow T.F., Youssef Y.M., Lianidou E., Romaschin A.D., Honey R.J., Stewart R., et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 2010, 43:150-158.
10. Jung M., Mollenkopf H.J., Grimm C., Wagner I., Albrecht M., Waller T., et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009, 13:3918-3928.
11. Nakada C., Matsuura K., Tsukamoto Y., Tanigawa M., Yoshimoto T., Narimatsu T., et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008, 216:418-427.
12. Juan D., Alexe G., Antes T., Liu H., Madabhushi A., Delisi C., et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010, 75:835-841.
13. Lee D.Y., Deng Z., Wang C.H., Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 2007, 104:20350-20355.
14. Feng M., Li Z., Aau M., Wong C.H., Yang X., Yu Q. Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 2011, 30:2242-2251.
15. Erdogan B., Facey C., Qualtieri J., Tedesco J., Rinker E., Isett R.B., et al. Diagnostic microRNAs in myelodysplastic syndrome. Exp Hematol 2011, 39:915-926.